v

Complete this and attach as a front cover sheet to every Assignment you submit for marking

Unit Code HI6008

Unit Name
Business Research Project

Your campus and class/tutorial number

(e.g. M2)
Your Lecturer/Tutor
Assignment Number
Is this a Group or Individual Assignment? If Group, state your assignment group number _________
Due Date

Declaration
1. This assignment is my/our own work. We have NOT copied any part of it from any other student’s work, neither from our own work in any
other subject/unit, whether at Holmes Institute or any other Educational Institution.

2. I/we have cited all sources from which data, ideas, diagrams, facts, or words (whether quoted directly or paraphrased) were taken.

3. This assignment was prepared specifically for this unit only and has not, nor will be used for any other unit.

4. The reference list is accurate and in Harvard referencing style and a true statement of the sources I/we have personally read and used.

Student name/s Student number Which section(s) did each person work
[must be correct] on
Research Development,
Student A Introduction, Conclusion,
referencing
Student B Literature Review, objectives,
Methodology, limitations,
research questions.
Student C Research Question, Research
limitation, key findings

Page 1 of 13
Introduction:

Artificial intelligence, simply defined is, the ‘theory and development of computer systems able
to perform tasks normally requiring human intelligence. These programs include the
recognition of speech, perception of visuals and translating several languages. Decision making
is also considered to be improved deliquently under the process.

Artificial Intelligence has become a crucial part of today’s era. Many industries cannot even
think of operating without the help of AI. However, like a coin has two sides, every concept has
its pros and cons. (Cowie, 2018)

Artificial Intelligence (AI) is the most exciting and promising new technology in today's world.
Artificial Intelligence (AI) is intelligence exhibited by computers, as opposed to natural (human
or animal) intelligence. AI, also known as Machine Intelligence, seeks to emulate human
intelligence by obtaining and applying data. It promises significant participation, significant
improvements, modernizations, and incorporation with and into people's daily lives. It makes
the environment more demanding and assists in making timely and effective decisions. This
paper offers a comprehensive examination of the health sector and health-care system in
Australia, as well as their implications for Artificial Intelligence (AI). This paper mainly used
secondary research analysis to provide a broad examination of the positive and negative
implications of health issues related to Artificial Intelligence (AI), as well as the architects of
those consequences and those overstated by the consequences. Journal papers, records,
academic conference proceedings, media articles, corporate documents, blogs, and other
relevant information are included in the secondary tools. Artificial Intelligence (AI) offers
valuable perspectives in the Australian healthcare system, according to the report. It is
gradually lowering the cost of the Australian healthcare system while also improving patients'
overall outcomes. Artificial Intelligence (AI) has the potential to not only strengthen relations
between government and health-care organizations, but also to improve people's lives by
increasing productivity and modernization. However, there are still many obstacles to tackle
before Australian healthcare can fully realize the promise of AI in health care, with ethics being
one of the most significant. Another aspect of the use of Artificial intelligence in the
pharmaceutical sector is that it is taking better risk management controls. Since he chances are
that there are lesser errors, the risks are reduced considerably as well. The use of AI helps the

Page 2 of 13
machines take various challenges in place of humans and therefore saves them from the risks
and hazards.

The topic that shall be discussed in this report is “Impact of Artificial Intelligence in the
Pharmaceutical Industry in Australia”. The Pharmaceutical industrial has seen many ups and
down int eh last few years. This sector requires a proper understanding of the needs and wants
of the enterprise. The pharmaceutical sector also requires an appropriate workforce to ease
the process. Many companies are located in rural areas which are not tech savvy, however the
sector is in much needed process of development of artificial intelligence to make sure that
there is a significant reduction in the errors. (Kalyane, 2020)

Initial literature search

It's fascinating to watch the growth of a sector that will disrupt the health-care industry and
the lives of billions of people. Machines can demonstrate Artificial Intelligence (AI) rather than
Natural (human) Intelligence. Computer-based intelligence, also known as Machine
Intelligence, aims to replicate human intuition by allowing users to secure and apply data and
skills.

Artificial intelligence can now be termed as the sleeping giant who is now awake to give new
wings to the pharmaceutical industry in Australia. It may sound exciting but it has drawback as
well as it shall conquer much of the workforce. It seems a bit strange that robots shall be
serving the humanity. However we can not deny the benefits that it is bringing by not only
improving the stock management but also helping is better outcomes fro patients, service
deliveries and dosing. Its benefits are much more than the adversities and pharmacies in
Australia are in no mood to ward off these advantages. (Karim, 2020)

AI in healthcare services was valued at USD 2.1 billion in 2018, according to the most recent
Australian statistical surveying, and is expected to be worth USD 36.1 billion by 2025. The most
cutting-edge medicinal services companies have only recently realized this and have
incorporated it into their practice. Organizational growth has resolved to have some kind of
impact in that space. Regardless, as AI covers a strong market - The Tech Industry - competition
will be fierce. It is not new; tech companies have been considering moving to social insurance
for quite some time. But, as we move closer to 2020, it will become more clear, and we will see

Page 3 of 13
the rise of various early-stage activities in a few applications. While this can pose a threat to
the medical services industry, it is not all doom and gloom; there is also hope.

The need for artificial intelligence became emergent when there was a desire in the reduction
of errors, these were the faults that were built upon the human error. This happened as
humans gave wrong input which resulted in fatalities.(Rees, 2020) Artificial intelligence aligns
the computers and programs adequately. Larger amount of data is processed easily without
any errors and defaults. The advantage of AI is that it helps in making operations easier and
also reduces costs. It minimizes the requirements of the workforce. On the other hand, AI will
also affect the unemployment and many industries such as the cottage industry, healthcare
sector, banking sector. These industries tend to adopt the traditional methods for their
functioning. The handicraft sector requires the workforce to work efficiently and effectively
because robots cannot do such work. If Artificial Intelligence enters the cottage industry, many
self-employed people will have to leave their job and move on the path of unemployment. The
next sector or let of the process which is impossible without people is the hiring or recruitment
sector. Only people can select the deserving candidate out of the crowd. AI might not be able
to work beyond the programming installed in the system. (Tierney, 2020)

Another aspect of the use of Artificial intelligence in the pharmaceutical sector is that it is
taking better risk management controls. Since he chances are that there are lesser errors, the
risks are reduced considerably as well. The use of AI helps the machines take various
challenges in place of humans and therefore saves them from the risks and hazards. (IBM,
2016)

Statement of Research Problem

the topic chosen is because Artificial intelligence has taken the pharmaceutical industry by
storm. Many companies are investing in huge infra structure costs to make sure that they are t
par with their industry counterparts. (Faggella, 2019) Therefore we would be considering the
good and bad impact of use of Artificial intelligence on the overall Pharmaceutical Industry in
Australia. Since it is a relatively explored field now we expect that our research shall provide
beneficial use for adaptive uses of technology in the pharmaceutical sector. Since the advert of
new problem such as virus and diseases, this industry and the methodology has gained
significant discussion therefore we would find considerable material that would form an
integral part of our research.

Page 4 of 13
Research Question

This research focuses on the various sectors of the Australian healthcare industry, such as
public hospitals, private hospitals, medical centers, and multiple health providers.
Since Australia is a developed country with strong ICT and AI industries, it was chosen as the
focus of this study.

“What is the Impact of Artificial Intelligence on the Pharmaceutical Industry in Australia”

The hypothesis that we shall be testing is whether there is any correlation between the
artificial industry and the net results of the pharmaceutical industry. We shall be adapting
literature review as well as quantitative analysis that shall encompass a significant part of this
report.

To find the answers we have to focus on the below questions:

• What kind of insights and business benefit will I get from using Artificial Intelligence (AI) in
healthcare?
• How do I calculate the expense of expanding the existing environment or implementing a
new approach in the health sector using AI?

• How would this affect current AI governance?

• Can I apply an Artificial Intelligence (AI) solution in stages?

• What basic skills are needed to comprehend and analyze the criteria for the Artificial
Intelligence (AI) solution's development and maintenance?

• Do I have some current AI infrastructure that could be used to provide market intelligence in
the healthcare industry?

• Is it possible for an Artificial Intelligence (AI) solution to aid the Australian healthcare
industry?

• Are health consumers well-informed about their health, healthcare options, and the cost and
quality of services and products available in the market?

• Are healthcare providers well-informed enough to provide each customer with timely and
ongoing care?

Page 5 of 13
• Do policymakers have a complete picture of consumers' health data, healthcare costs and
quality, and likely future demand trends in the health sector to make informed decisions?
• Do public and private healthcare funders have enough knowledge to make evidence-based
funding and payment decisions?

• Do researchers have access to sufficient amounts of healthcare data to conduct research that
will inform the type, expense, and quality of services, as well as healthcare planning and
delivery?

Research Methodology:

The strategy consists of a number of steps including the following:

 Problem Identification, to start a basis for our research process.

 Data Collection, the data would be collected through a structured questionnaire.
 Data Analysis, to make the hypothesis testing. Literature review will form a strong part
of this research.
 Data Interpretation, as the data is qualitative so, the scale of interpretation is
qualitative.
 Research Findings, with the help of data interpretation, the research findings have been
presented.
 Recommendations, the recommendations will represent the future course of action.

Research Limitations:

We have assumed that there is enough literature review available for us to start a basis of our
report. We shall identify significant means that would form a qualitative research part of this
report. However since the field is ever evolving, we might not be able to have the latest set of
implications. However, we have decided that literature review shall form just one part of the
analysis, quantitative analysis in form of questionnaires and statistical analysis shall also be
done to further legitimate our assumptions and final decisions. Since it is an open topic, we are
sure that we shall get open and correct responses from the people.

Page 6 of 13
Objectives of Research

 Learning about the history of the ICT industry, AI technology, Artificial Intelligence (AI)
challenges and opportunities, and the importance of business in health in Australian
healthcare.

 To trace the development of Artificial Intelligence (AI) in Australian healthcare from its
inception to the present.

 Identifying the criteria for a successful evaluation in service SMEs; determining the
causes, challenges, and opportunities for the fastest progress in the ICT and Artificial
Intelligence (AI) industry in Australian Healthcare; and determining the reasons,
challenges, and opportunities for the fastest improvement in the ICT and Artificial
Intelligence (AI) industry in Australian Healthcare.

 Identifying the current role of the frame for calculating Artificial Intelligence (AI) in the
Australian healthcare industry.

 Using Artificial Intelligence (AI) to categorize common factors for consumer and
business satisfaction in the Australian healthcare sector.

 Extending a good evaluation for Artificial Intelligence (AI) satisfaction in the Australian
healthcare market.

 Considering the economic, legal, social, ethical, and political implications of Artificial
Intelligence (AI) in Australian healthcare.

 Learning how stable ICT and Artificial Intelligence (AI) will contribute to Australia's
healthcare industry's economic growth

Aim of Study:

The aim of this research is to determine the effects of AI on the Australian healthcare industry,
in order to gain a better and clearer understanding of the scope for future growth and
advancement in the Artificial Intelligence (AI) sector.

Page 7 of 13
Key findings:

Artificial Intelligence (AI) is seen as a promising resource for boosting the Australian healthcare industry.
Australian healthcare needs to incorporate Artificial Intelligence (AI) more comprehensively, as it both
has promise and can't afford to be overlooked. The Australian Healthcare sector has spearheaded a
number of initiatives aimed at advancing Artificial Intelligence (AI) research.
The following are some main findings that have been valued in this section:

The Applications of Artificial Intelligence (AI) in Australian Healthcare

Client Perspectives: AI will learn from the data, predict future events, and act on the knowledge it
generates. AI enables human resources companies to communicate with clients more easily thanks to
the combination of AI and Data Analytics/Business Intelligence.

Robotized Data and Record Management: Every day activities generate a massive amount of data and
paperwork, which can increase the amount of time human resources professionals spend on
administrative tasks. Artificial intelligence can accurately and appropriately manage information and
archives, enabling human resources professionals to focus on more important projects and patients
(Durant 2016).

Diagnosis of the patients: With advances such as Google Cloud Intelligence Video, AI will soon be able
to assist HCPs in therapeutic picture investigation, such as detecting malignancy with an X-Ray. Filtering
Electronic Health Records is another way AI might help with patient analysis, among a variety of other
things (Petryni 2016).

Effectiveness of Medicines: Companies are looking at using AI to predict how individual patients will
respond to specific drugs. Max Kelsen, an Australian research firm, will use AI and genome data in
collaboration with GenomiQa to predict the efficacy of malignant growth medicines (Harry 2017).

Medication Discovery: Artificial Intelligence (AI) is pushing and speeding up new rational disclosures. In
December 2019, DeepMind, a Google subsidiary based in Australia, announced its ability to use AI to
create 3D states of proteins based on their inherited arrangement. Protein collapsing is important in the
development of illnesses and drugs, and it has long been a difficult and time-consuming test for

Page 8 of 13
conventional researchers. For analysts, this model implies that AI could help them become more
proficient in the medication disclosure process (James 2019).

Human Augmentation: Artificial intelligence (AI) can be used to enhance human abilities. This area
opens up a wide range of very cutting-edge applications at the individual level, as well as at the
hierarchical level, where the market can be divided between AI-enabled organizations and the rest. AI
advancements are reshaping the human resources sector and patient care. However, after we've
progressed beyond the stage of creativity, we still have a long way to go before we can fully exploit AI's
potential - one of the most basic being ethics.

Artificial Intelligence (AI): A Joint Narrative on Health Applications

• Artificial Intelligence (AI) is a collaborative account on its future use in paediatric stem and
invulnerable cell therapies, as well as regenerative medicine (Irena 2018).

• Artificial Intelligence (AI) is a deeply appealing scholastic area with various current fields of studies
(Petryni 2016). It mirrors the experience shown by computers and programming.

• Thought, information, organizing, learning, common language preparation (correspondence),

discernment, and the ability to move and manage objects are the main goals of AI research (James
2019).

The multidisciplinary AI area is interdisciplinary, encompassing a wide range of sciences and professions
such as software engineering, brain studies, etymology, reasoning, and neurosciences, among others
(James 2018).
• Artificial Intelligence (AI) has received a lot of positive press, but it has also faced a lot of challenges
(James 2019).

• An emphasis is placed on the recognition and application of AI procedures in the development of

predictive models for personalized medicines using undifferentiated species, susceptible cells, and
recovered tissues in adults and children (James 2019).

• In a matter of minutes, these perceptive machines could analyze the entire genome and isolate the

Page 9 of 13
resistant particularities of each patient's illness, allowing them to tailor care to the patient's genetic
explicitness and insusceptible framework ability.

• AI strategies could be used to improve clinical preliminaries of creative immature microorganisms and
quality treatments in paediatric patients by precisely arranging medicines, anticipating clinical results,
streamlining patient enrolment and maintenance, gaining from input data and applying to new data,
lowering their unpredictability and costs (James 2019).

• Artificial Intelligence (AI) has begun to disrupt a number of areas of medicine, ranging from the design
of treatment proof-based treatment strategies to the application of ongoing logical advances (James
2018).

• There is a growing understanding of AI capabilities, as well as excitement for using algorithmic,

computational, and observable models to deliver life-saving biomedical research outcomes.
There are currently a large number of ongoing AI-related projects in various fields of research,
pharmaceuticals, and medical services (Petryni 2016).

Conclusion:

Artificial Intelligence (AI) has tremendous potential in a variety of medical fields, especially in the
effective delivery of invulnerable and regenerative treatments. Progressing AI research is now
improving and supplementing a wide range of areas, from diagnostics to care plan structuring and
human services across the board. AI advances in the future will also hasten progress in biomedical and
pharmaceutical science, as well as in human services. There is compelling evidence that AI may play a
critical role in assisting clinicians in effectively delivering their administrations in the twenty-first
century. It is natural that AI will change medicine and human services, but only when it is made
available to the general public (rather than restricted to standard up specialists' audit of boring data)
and directed toward deep learning approaches that create new and obscure connections between data.
Who will win this new data race will be determined not just by how much money is invested, but also
by how successfully and cooperatively researchers, doctors, and other organizations will send these
new data mining instruments to their cooperative projects. Such community-building approaches can
also be used to address the problem of scholarly properties. In the meantime, what is most energizing
today is a step away from AI systems (apparatuses to free).

Page 10 of 13
References:

1. Amsah.org. (2019). Artificial Intelligence (AI) in Healthcare 2019 Australia. [online]

Available at: https://amsah.org/ [Accessed 19 Apr. 2021].

2. Cole, C.H. (2019). Patients expect transparency in doctors’ relationships with the
pharmaceutical industry. Medical Journal of Australia, 190(8), pp.459–461.

3. Cowie, T. (2018). Artificial Intelligence - real opportunities. [online] Australian

Pharmacist. Available at: https://www.australianpharmacist.com.au/artificial-
intelligence-real-opportunities/.

4. Dekkers, J. (2014), COIS 19701: Research Methods: Study Guide, Central Queensland

University, Rockhampton, Queensland. Department of Premier and Cabinet. (2012, May

16). NSW Premier & Cabinet, NSW Government Website Management, retrieved from:
http://arp.nsw.gov.au/c2012-08-nsw-government-website-management A world that
counts: mobilizing the data revolution for sustainable development. Technical report,
United Nations, 2014, retrieved from: http://thenextweb.com/insider/2015/11/17/the-
state-of-Artificial Intelligence(AI)-in-the-us-state-by-state-report-2

5. Demach, R. (2020). Artificial intelligence in healthcare. [online] www.siemens-

healthineers.com. Available at: https://www.siemens-healthineers.com/en-au/digital-
health-solutions/artificial-intelligence-in-healthcare [Accessed 9 May 2021].

6. Durant F, Lobo D, Hammelman J, Levin M. Physiological controls of large-scale

patterning in planaria regeneration; a molecular and computational perspective on
growth and form. Regeneration 2016;28(April (2)):78–102

7. I. Sniecinski, J. Seghatchian Transfusion and Apheresis Science 57 (2018) 422–424 424

Harry Klimis, retrieved from
http://sydney.edu.au/medicine/people/academics/profiles/harry.klimis.php

8. Irena Sniecinskia, Jerard Seghatchianb, Transfusion and Apheresis Science 57 (2018)

422–424 Uses of AI for health issues people Might Not Have Thought About.
https://www.pardot.com/blog/

Page 11 of 13
 9. Faggella, D. (2019). Where Healthcare’s Big Data Actually Comes From. [online] Emerj.

Available at: https://www.techemergence.com/where-healthcares-big-data-actually-

comes-from/ . [Accessed 20 Apr. 2021].

10. Hodges, R. and Lapsley, I. (2016). A Private Sector Failure, a Public Sector Crisis -
Reflections on the Great Recession. Financial Accountability & Management, 32(3),
pp.265–280.

11. Kalyane, D., Sanap, G., Paul, D., Shenoy, S., Anup, N., Polaka, S., Tambe, V. and Tekade,

R.K. (2020). Artificial intelligence in the pharmaceutical sector: current scene and future
prospect. The Future of Pharmaceutical Product Development and Research, pp.73–107.

12. Karim, Shakir & Sandu, Raj (2020). A study to analyse the impact of artificial intelligence
(AI) in transforming Australian healthcare. [online] Available at: 10.18844/gjit.v%vi
%i.4533

13. NBC News. (2020). Why Big Pharma and biotech are betting big on AI. [online] Available

at: https://www.nbcnews.com/mach/science/why-big-pharma-betting-big-ai-
ncna852246.

14. Rees, V. (2020). Optimising artificial intelligence in the pharmaceutical industry. [online]
Available at:
https://www.europeanpharmaceuticalreview.com/article/107772/optimising-artificial-
intelligence-in-the-pharmaceutical-industry/.

15. Petryni, M. (2016). Small Business. Difference Between Strategic & Operational
Objectives, http://smallbusiness.chron.com/difference-between-strategic-operational-
objectives-24572.html

16. S. Berne, A. (2019). Event Report - Big Data in the Pharmaceutical Sector. European
Pharmaceutical Law Review, 3(1), pp.37–45.

17. Tierney, S. (2020). Artificial intelligence in pharma: utilising a valuable resource. [online]
European Pharmaceutical Review. Available at:
https://www.europeanpharmaceuticalreview.com/article/114914/artificial-intelligence-
in-pharma-utilising-a-valuable-resource/.

Page 12 of 13
 18. Tillmanns, C. and Fuderer, M. (2019). Artificial Intelligence as an Emerging Technology
in the Pharmaceutical Industry: What are the Legal Challenges? European
Pharmaceutical Law Review, 3(1), pp.3–10.

19. Walch, K. (2019). The Increasing Use Of AI In The Pharmaceutical Industry. [online]
Forbes. Available at: https://www.forbes.com/sites/cognitiveworld/2020/12/26/the-
increasing-use-of-ai-in-the-pharmaceutical-industry/?sh=61652a3c4c01 [Accessed 21
Apr. 2021].

20. Writer, S. (2017). World’s largest pharmaceutical researcher testing Australian-made

artificial intelligence. [online] Manufacturers’ Monthly. Available at:
https://www.manmonthly.com.au/news/worlds-largest-pharmaceutical-researcher-
testing-australian-made-artificial-intelligence/ [Accessed 21 Apr. 2021].

21. IBM. (2016). IBM and Pfizer to Accelerate Immuno-oncology Research with Watson for
Drug Discovery. [online] Available at: https://www-
03.ibm.com/press/uk/en/pressrelease/51192.wss [Accessed 21 Apr. 2021].

Page 13 of 13